4 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 2 | Terminated 2 |
Follow Carcinosarcoma: new trials by email Literature Review of Carcinosarcoma trials Research Report on Carcinosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors INCB099280, axitinib - Advanced Solid Tumors | Phase 1 / Phase 2 | Terminated | Incyte Corporation | 5 | 2024-04-16 | 2026-06-04 |
| A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes Rucaparib - Solid Tumor | Phase 2 | Terminated | pharmaand GmbH | 83 | 2020-01-16 | 2023-10-02 |
| A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors Rebastinib, Paclitaxel - Locally Advanced or Metastatic Solid Tumor | Phase 1 / Phase 2 | Terminated | Deciphera Pharmaceuticals, LLC | 177 | 2018-10-25 | 2024-12-27 |
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy Carboplatin, Cisplatin, Paclitaxel - Uterine Neoplasms | Phase 2 | Terminated | M.D. Anderson Cancer Center | 4 | 2002-02-01 | 2011-09-15 |
Ovarian Neoplasms (3) · Breast Neoplasms (2) · Endometrial Neoplasms (2) · Fallopian Tube Neoplasms (2) · Neoplasm Metastasis (2) · Uterine Cervical Neoplasms (2) · Uterine Neoplasms (2) · Adenocarcinoma, Mucinous (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Cystadenocarcinoma, Serous (1) · Esophageal Neoplasms (1) · Leiomyosarcoma (1) · Lung Neoplasms (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Complex and Mixed (4) · Neoplasms, Connective and Soft Tissue (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Uterine Diseases (4) · Adnexal Diseases (3) · Endocrine Gland Neoplasms (3)
Paclitaxel (2) · Axitinib (1) · Carboplatin (1) · Cisplatin (1) · DCC-2036 (1) · rebastinib (1) · rucaparib (1)
Deciphera Pharmaceuticals, LLC (1) · Incyte Corporation (1) · M.D. Anderson Cancer Center (1) · pharmaand GmbH (1)
United States (3) · United Kingdom (1)
Kim Reiss-Binder, MD (1) · Lois M. Ramondetta, MD (1) · Philomena Colucci (1)
2023 (1)